Kates
In December they said they had 10 evaluable patients with best responses of 5 PR and 4 SD.
In the January presentation they still listed 5 PR and 4 SD.
In February they listed 1 CR, 5 PR and 4 SD. If this is accurate then it suggests that there's been a change in best responses, 1 patient has improved to at least SD(they were previously not mentioned apart from being one of the evaluable 10) and someone has improved to CR(yay). If this is a result of ongoing dosing then it's a hell of a thing. Or have I got things out of whack?
Conjecture, YMMV.
Cheers
l c interview, page-18
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
